Recent Finacing
Recent Raise
TopiVert develops topical anti-inflammatory drugs for eye and gut diseases, using narrow-spectrum kinase inhibitor (NSKI) technology, operating from the Imperial College Incubator and collaborating with RespiVert.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors